Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
NDEA Contamination Leads To Another Valsartan Recall January 3, 2019 Irvin Jackson Add Your Comments Another batch of generic blood pressure medications containing the active ingredient valsartan are being recalled, due to a risk that they may be contaminated with a cancer-causing impurity, N-nitrosodiethylamine (NDEA). On December 31, the FDA announced an Aurobindo Pharma USA recall, affecting certain lots of valsartan tablets, as well as amiodipine valsartan and valsartan hydrochlorothiazide (HCTZ) tablets. The recall came after trace amounts of NDEA contamination were confirmed, which is a known human carcinogen. The action is the latest in a string of valsartan NDEA recalls issued in recent months, as well as other recalls due to a similar impurity, N-nitrosodimethylamine (NDMA), which was detected in valsartan made by certain Chinese manufacturers last summer. This is at least the third recall involving products made by Aurobindo. VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION VALSARTAN LAWSUITS Were you prescribed contaminated Valsartan drugs? Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The recall affects 80 lots of Amiodipine Valsartan Tablets, USP, Valsartan HCTZ Tablets, USP, and Valsartan Tablets USP, which are all indicated to control high blood pressure and the treatment of heart failure. The recalled tablets were all sold in 30 or 90 count bottles with expiration dates ranging from 07/2019 to 03/2021. A complete list of lot numbers, NDC numbers, expiration dates, names and strengths is available in the FDA recall notice. The notice urges patients to continue taking the medications until they decide on an alternative treatment with their physician or pharmacist, as the immediate harm of stopping hypertension treatment may be a greater risk than exposure to NDEA, which requires years of exposure before it is considered a cancer risk. Valsartan Recalls The first valsartan problems surfaced on July 5, after European regulators announced that batches of the active ingredient supplied by Zhejiang Huahai Pharmaceuticals tested positive for NDMA. The FDA followed with its own recall announcement on July 13, indicating that the agency had launched an investigation to determine the scope of the contamination and the potential risk to consumers. In late September, the FDA stopped all imports of drug ingredients and medicines made by Zhejiang Huahai Pharmaceuticals, after an inspection report outlined a number of serious manufacturing problems at the company’s facility in late August. The recalls have led to a valsartan shortage and a spike in prices, with the cost of 160 milligram and 80 milligram tablets of generic valsartan more than doubling in September 2018. As consumers nationwide continue to face concerns about the safety of pills they have taken in recent years, a number of valsartan recall class action lawsuits have been filed nationwide, seeking damages for the cost of the recalled drugs and medical monitoring. For those diagnosed with liver cancer, kidney cancer, pancreatic cancer, stomach cancer and other cancers, individual cases are being reviewed by valsartan lawyers. The FDA has assigned a group of pharmacists and nurses to answer consumer’s questions about the recalls. Since the first recalls, the agency indicates it has received more than 6,000 inquiries from patients, doctors, nurses, pharmacists and academics. Inquiries can be made by calling 855-543-3784 or by sending an email to druginfo@fda.hhs.gov. Consumers are urged to contact their doctor if they have experienced any problems that may be related to the recalled valsartan. Healthcare professionals and patients are urged to report adverse events to FDA’s MedWatch adverse event reporting program. Consumers with medical questions or who want to report an adverse event involving this latest recall can contact Aurobindo Pharma USA at 1-866-850-2876, or by sending an email to pvg@aurobindousa.com. Tags: Aurobindo, Cancer, Drug Recall, Hypertension, Valsartan More Valsartan Lawsuit Stories Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025 Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025 Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits February 20, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: yesterday) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025) DraftKings Class Action Lawsuit Alleges Enormous Revenue Generated by Misleading Gamblers (Posted: yesterday) A class action lawsuit accuses popular sports betting site, DraftKings, of using misleading advertising and personal data to create gambling addicts. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings and FanDuel Lawsuit Alleges Sportsbooks Engage in Deceptive Practices To Exploit Gambling Addiction (04/09/2025)Gambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025) Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: 2 days ago) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025)
Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named March 27, 2025
Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025
Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: yesterday) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)
DraftKings Class Action Lawsuit Alleges Enormous Revenue Generated by Misleading Gamblers (Posted: yesterday) A class action lawsuit accuses popular sports betting site, DraftKings, of using misleading advertising and personal data to create gambling addicts. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings and FanDuel Lawsuit Alleges Sportsbooks Engage in Deceptive Practices To Exploit Gambling Addiction (04/09/2025)Gambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)
Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: 2 days ago) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025)